• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Chung Yin (Joey) Kong, PhD


  • Rose J, Augestad KM, Kong CY, Meropol NJ, Kattan MW, Hong Q, An X, Cooper GS.A simulation model of colorectal cancer surveillance and recurrence.BMC Med Inform Decis Mak. 2014;14(1):29.
  • de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammem├Ągi MC, Hazelton WD, Feuer EJ, McMahon PM.Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.Ann Intern Med. 2014 Mar 4;160(5):311-20.
  • Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle C, Miller M, Choi SE, Lansdorp-Vogelaar I, van Ballegooijen M, Feuer EJ, Inadomi JM, Hur C, Luebeck EG.Exploring the Recent Trend in Esophageal Adenocarcinoma Incidence and Mortality Using Comparative Simulation Modeling.Cancer Epidemiol Biomarkers Prev. 2014 Apr 1.
  • Meza R, Ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK.Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.Cancer. 2014 Feb 27.
  • Choi SE, Perzan K, Tramontano AC, Kong CY, Hur C.Statins and Aspirin for Chemoprevention in Barrett's Esophagus: Results of a Cost-Effectiveness Analysis.Cancer Prev Res (Phila Pa). 2013 Dec 31.
  • Swan JS, Kong CY, Lee JM, Itauma O, Halpern EF, Lee PA, Vavinskiy S, Williams O, Zoltick ES, Donelan K.Patient and societal value functions for the testing morbidities index.Med Decis Making. 2013 Aug;33(6):819-38.
  • Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM.Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.AJR Am J Roentgenol. 2013 May;200(5):1020-7.
  • Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS.Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.Cancer. 2013 Mar 15;119(6):1266-76.
  • Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ.Trends in esophageal adenocarcinoma incidence and mortality.Cancer. 2013 Mar 15;119(6):1149-58.
  • Pandharipande PV, Eisenberg JD, Lee RJ, Gilmore ME, Turan EA, Singh S, Kalra MK, Liu B, Kong CY, Gazelle GS.Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox.Radiology. 2013 Mar;266(3):896-904.
  • Hur C, Choi SE, Rubenstein JH, Kong CY, Nishioka NS, Provenzale DT, Inadomi JM.The cost effectiveness of radiofrequency ablation for Barrett's esophagus.Gastroenterology. 2012 Sep;143(3):567-75.
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS.Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.Risk Anal. 2012 Jul;32 Suppl 1:S117-24.
  • Fennessy FM, Kong CY, Tempany CM, Swan JS.Quality-of-Life Assessment of Fibroid Treatment Options and Outcomes.Radiology. 2011 Mar 1.
  • Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E.Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing.Qual Life Res. 2010 Apr;19(3):401-12.
  • Hur C, Hayeck TJ, Yeh JM, Richards EB, Spechler SJ, Gazelle GS, Kong CY.Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.PLoS ONE. 2010;5(3):e9483.
  • Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS.Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.Radiology. 2010 Mar;254(3):793-800.
  • Prosser LA, Kong CY, Rusinak D, Waisbren SL.Projected costs, risks, and benefits of expanded newborn screening for MCADD.Pediatrics. 2010 Feb;125(2):e286-94.
  • Kong CY, McMahon PM, Gazelle GS.Calibration of disease simulation model using an engineering approach.Value Health. 2009 Jun;12(4):521-9.
  • Hur C,Broughton DE,Kong CY,Ozanne EM,Richards EB,Truong T,Gazelle GS.Patient Preferences for the Chemoprevention of Colorectal Cancer.Dig Dis Sci. 2009 Oct;54(10):2207-14.
  • Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS.Calibration methods used in cancer simulation models and suggested reporting guidelines.Pharmaco Economics. 2009;27(7):533-45. Review.
  • C.Y. Kong, P.M. McMahon, and G.S. Gazelle.Calibration of Disease Simulation Model Using an Engineering Approach.VIH..
  • McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.Adopting helical CT screening for lung cancer : potential health consequences during a 15-year period.Cancer. 2008 Dec 15;113(12):3440-9.
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS.Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study.Radiology. 2008 Jul;248(1):278-87.
  • Yeh JM,Kuntz KM,Ezzati M,Hur C,Kong CY,Goldie SJ.Development of an empirically calibrated model of gastric cancer in two high-risk countries.Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1179-87.
  • Muthukumar M, Kong CY.Simulation of polymer translocation through protein channels.Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5273-8.
  • Kong CY, Muthukumar M.Simulations of stochastic sensing of proteins.J Am Chem Soc. 2005 Dec 28;127(51):18252-61.
  • Kong CY, Muthukumar M.Polymer translocation through a nanopore. II. Excluded volume effect.J Chem Phys. 2004 Feb 15;120(7):3460-6.
  • Kong CY, Muthukumar M.Modeling of polynucleotide translocation through protein pores and nanotubes.Electrophoresis. 2002 Aug;23(16):2697-703.